Agilent Technologies

Agilent Technologies, Inc. is a prominent provider of laboratory solutions focused on the life sciences, diagnostics, and applied chemical markets globally. The company operates through three main segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. It offers a wide range of instruments and technologies, including chromatography systems, mass spectrometry, spectroscopy, and cell analysis tools, aimed at enhancing laboratory efficiency and data management. Agilent also specializes in genomic analysis, providing tools for DNA mutation detection, gene expression profiling, and quality control of nucleic acid samples. Furthermore, the Agilent CrossLab segment delivers consumables, training, and consultation services to support laboratory operations. The company markets its products via direct sales, distributors, and electronic commerce, serving diverse sectors such as biopharmaceuticals, environmental testing, forensics, and food safety. Founded in 1999 and headquartered in Santa Clara, California, Agilent Technologies continues to innovate and collaborate with various organizations to address critical scientific needs.

Padraig McDonnell

President, CEO and Board Member

Sam Raha

Senior Vice President, Agilent and President, Diagnostics and Genomics Group

77 past transactions

Halo Labs

Series C in 2022
Halo Labs (formerly Optofluidics) is a venture-backed scientific instrumentation company that commercializes high throughput biopharmaceutical quality control tools using the latest optics, image processing, and microfluidics. Its investors and development partners include BioAdvance, the National Science Foundation, the Defense Advanced Research Projects Agency, and the Ben Franklin Technology Partners. In 2012 Optofluidics was named Philadelphia Life Sciences startup of the year. The company was founded in 2011 and headquartered in Pennsylvania, United States.

Arima Genomics

Series B in 2022
Arima Genomics develops solutions to drive genomics discovery and human health. Their services include study design consultation, sample preparation, library preparation, bioinformatics analysis, and data interpretation. Their Hi-C technology enables researchers to build chromosome-scale assemblies. Their chromosomal loop arrangement introduces regulatory elements, resulting in altered function.

Molecular Assemblies

Series B in 2022
Molecular Assemblies is a San Diego-based company developing a revolutionary, enzymatic DNA synthesis technology capable of powering new products in industrial synthetic biology, personalized therapeutics, precision diagnostics, and eventually information storage, nanotechnology and more. Inspired by nature, the company’s proprietary DNA synthesis method is designed to produce long, high quality, sequence-specific DNA reliably, affordably and sustainably. With a highly experienced executive and scientific team and an expansive intellectual property portfolio, Molecular Assemblies has attracted investments from Agilent Technologies, Cavendish Impact Capital Fund, Data Collective Venture Capital, Eleven Two Capital, Genomics Investment Syndicate, Keshif Ventures, Newport Holdings, LP, and Alexandria Venture Investments.

PreciseDx

Series A in 2022
PreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology features, enabling better and more personalized treatment and outcomes. Clinical teams can rely on PreciseDx for unmatched insights and actionable intelligence in determining the best treatment for each patient. Combining the power of artificial intelligence with its proprietary Morphology Feature Array™, PreciseDx creates disease-specific assays that deliver new levels of pathology information and insight on each patient's risk profile and likely outcomes to aid in treatment decision-making.

Nicoya Lifesciences

Series A in 2021
Nicoya is a provider of advanced analytical instruments for the biotechnology and pharmaceutical industries.

RareCyte

Series G in 2021
RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood. RareCyte is dedicated to bringing its innovative technology to the Life Sciences research, drug development, and diagnostic markets providing new tools to answer difficult questions related to cancer and cardiovascular disease. RareCyte's AccuCyte system is an open platform for the unbiased discovery and isolation of circulating tumor cells (CTCs) and circulating endothelial cells (CECs) from whole blood.

Mobilion Systems

Series C in 2021
MOBILion Systems is a biotechnology company that specializes in identifying and analyzing the most challenging molecules that other instruments fail to detect. Its technology focuses on biologic therapeutics, discovering biomarkers, and improving the accuracy of diagnostic tests.MOBILion’s technology makes it easy to separate, identify, and analyze the most challenging molecules that other instruments fail to detect. The company's analytical instruments provide unprecedented sensitivity, resolution, and throughput that will fuel the development of better therapeutics, the ability to detect disease earlier, and the power to attack diseases at their roots instead of their symptoms.

Molecular Assemblies

Series A in 2021
Molecular Assemblies is a San Diego-based company developing a revolutionary, enzymatic DNA synthesis technology capable of powering new products in industrial synthetic biology, personalized therapeutics, precision diagnostics, and eventually information storage, nanotechnology and more. Inspired by nature, the company’s proprietary DNA synthesis method is designed to produce long, high quality, sequence-specific DNA reliably, affordably and sustainably. With a highly experienced executive and scientific team and an expansive intellectual property portfolio, Molecular Assemblies has attracted investments from Agilent Technologies, Cavendish Impact Capital Fund, Data Collective Venture Capital, Eleven Two Capital, Genomics Investment Syndicate, Keshif Ventures, Newport Holdings, LP, and Alexandria Venture Investments.

Resolution Bioscience

Acquisition in 2021
Resolution Bioscience is pioneering next-generation cancer diagnostics that enable physicians to tailor treatments for each patient using only a blood test — a liquid biopsy. Resolution Bioscience's proprietary molecular analytics platform interrogates cell-free DNA for actionable information that, until now, has only been accessible through invasive biopsy procedures. Resolution Bioscience has developed over 50 focused panels and is currently working on companion diagnostics to support therapeutic approvals. Resolution Bioscience is dedicated to improving cancer outcomes through a suite of clinical tests to guide the selection of targeted therapies and monitor their effectiveness over time.

Cardea Bio

Series A in 2020
Cardea is developing a new generation of (bio)technology infrastructure based on proprietary biology-gated transistors. Cardean transistors leverage biocompatible graphene instead of silicon and replace optical signal observations with direct electrical molecular signal analysis. With Cardean transistors, the company and its Innovation Partners can generate streaming multi-omics data to measure real-time biological signals. Cardea is now manufacturing chips at scale and partners have started to significantly expand the amount, type, and quality of biological data they capture by building products that Conduct Biolog.

Mobilion Systems

Series B in 2020
MOBILion Systems is a biotechnology company that specializes in identifying and analyzing the most challenging molecules that other instruments fail to detect. Its technology focuses on biologic therapeutics, discovering biomarkers, and improving the accuracy of diagnostic tests.MOBILion’s technology makes it easy to separate, identify, and analyze the most challenging molecules that other instruments fail to detect. The company's analytical instruments provide unprecedented sensitivity, resolution, and throughput that will fuel the development of better therapeutics, the ability to detect disease earlier, and the power to attack diseases at their roots instead of their symptoms.

DNA Script

Series B in 2020
DNA Script is a disruptive DNA synthesis company engineering biology to accelerate breakthroughs in life science and human health. Their revolutionary enzymatic technology powers the world's first benchtop DNA printer, SYNTAX, enabling labs to print their own synthetic oligos for greater workflow control and faster access to results.

Arima Genomics

Series A in 2020
Arima Genomics develops solutions to drive genomics discovery and human health. Their services include study design consultation, sample preparation, library preparation, bioinformatics analysis, and data interpretation. Their Hi-C technology enables researchers to build chromosome-scale assemblies. Their chromosomal loop arrangement introduces regulatory elements, resulting in altered function.

Mobilion Systems

Series A in 2019
MOBILion Systems is a biotechnology company that specializes in identifying and analyzing the most challenging molecules that other instruments fail to detect. Its technology focuses on biologic therapeutics, discovering biomarkers, and improving the accuracy of diagnostic tests.MOBILion’s technology makes it easy to separate, identify, and analyze the most challenging molecules that other instruments fail to detect. The company's analytical instruments provide unprecedented sensitivity, resolution, and throughput that will fuel the development of better therapeutics, the ability to detect disease earlier, and the power to attack diseases at their roots instead of their symptoms.

Molecular Assemblies

Series A in 2019
Molecular Assemblies is a San Diego-based company developing a revolutionary, enzymatic DNA synthesis technology capable of powering new products in industrial synthetic biology, personalized therapeutics, precision diagnostics, and eventually information storage, nanotechnology and more. Inspired by nature, the company’s proprietary DNA synthesis method is designed to produce long, high quality, sequence-specific DNA reliably, affordably and sustainably. With a highly experienced executive and scientific team and an expansive intellectual property portfolio, Molecular Assemblies has attracted investments from Agilent Technologies, Cavendish Impact Capital Fund, Data Collective Venture Capital, Eleven Two Capital, Genomics Investment Syndicate, Keshif Ventures, Newport Holdings, LP, and Alexandria Venture Investments.

BioTek Instruments

Acquisition in 2019
BioTek Instruments focuses in the manufacturing, development, and sale of life science instrumentation and software, including imaging and microscopy, multi-mode detection, liquid handling, and automation systems. The company's philosophy transcends conventional thinking and challenges the status quo. It develops fresh, original solutions by unifying concepts that often appear to be opposed. It means to shape and reshape. To engineer, build, deliver, and support products that best serve the marketplace by providing what people need, when needed.

Purigen Biosystems

Series B in 2019
Purigen Biosystems' innovative products offer a truly transformative solution for DNA and RNA purification. Their proprietary approach uses isotachophoresis to separate nucleic acids freely in solution without binding or stripping from a physical surface. Because of this, their technology is agnostic to nucleic acid size or sequence and delivers unbiased results ― even from the more challenging sample types like FFPE tissue or low cell counts. Their Ionic Purification System and Kits combine to provide researchers with a fast, efficient, and effective alternative for automated nucleic acid purification.

Mission Bio

Series B in 2018
Mission Bio delivers targeted solutions for high-impact applications with the Tapestri Platform. The Tapestri Platform is the industry’s first and only single-cell multi-omics platform, enabling genotype and phenotype from the same cell and precise detection of heterogeneity in disease progression and treatment response. Application areas include oncology blood cancers, solid tumors, and genome editing validation.

ACEA BIO

Acquisition in 2018
ACEA Biosciences is a biotechnology company founded in 2002 and headquartered in San Diego, California. ACEA is a pioneer in the development and commercialization of high-performance microelectronic systems for cell-based assays. ACEA has a world-class manufacturing operation centered in Hangzhou, Zhejiang Province, China. The Life Technology Business Unit developed ACEA’s proprietary real-time, label-free cell-based assay technology and launched the first product in 2004. The technology has been marketed globally under the xCELLigence brand. There are over 800 customers worldwide, and over 350 peer-reviewed publications using the xCELLigence technology. The newly launched iCELLigence instrument with wireless connectivity makes this innovative technology affordable to all users. In addition to the Life Technology Business Unit, ACEA also has a Therapeutics Business Unit which was launched in 2005. ACEA Therapeutics is focused on oncology drug discovery and development, leveraging the platform biosensor technology and proprietary small molecule library (> 1 million compounds) to bring novel therapeutics into the clinic. ACEA currently has one program in phase II clinical trials in China and numerous early clinical and preclinical leads. With its international reach, ACEA Biosciences continues to work closely with scientists throughout the world to bring innovation to the R&D and health care industries.

ULTRA Scientific

Acquisition in 2018
ULTRA has been a world-wide producer and industry leader in certified reference materials and other laboratory solutions. It services the environmental, pharmaceutical, biotechnology, life science and molecular testing laboratories.

Genohm

Acquisition in 2018
At Genohm we believe that every scientist deserves to organize his digital data management system according to his own needs and matching closely his own laboratory workflows. We have established our expertise in software automation solutions covering LIMS + ELN + order management. Today, a wide range of international clients such as Biobanks, research (R&D) and Next Generation Sequencing (NGS) laboratories in Universities and hospitals, as well as Biotech companies trust our SLims platform.”

Lasergen

Acquisition in 2018
LaserGen, Inc., a biotechnology company, engages in the development and commercialization of technologies for genomics application. It develops various technologies for sequencing applications. The company's products detect heritable and somatic sequence variations in the human genome for use as diagnostics tools for the management of diseases. LaserGen, Inc. was incorporated in 2002 and is based in Houston, Texas.
Advanced Analytical Technologies, Inc. develops, manufactures, and markets nucleic acid and genetic analysis systems to customers in the United States and Germany. The company’s products have commercial and research applications, and are designed to improve processes within the molecular diagnostics, pharmaceutical, life science, agricultural, and biofuels industries. It offers Fragment Analyzer, an instrument that is used for DNA, gDNA, and RNA quality control; Zero Agarose Gel DNA Analyzer, a capillary electrophoresis system that is used in laboratories for automated analysis of DNA fragments; Oligo PRO for size-based purity analysis of single-stranded DNA and RNA oligonucleotides, or double-stranded RNA interference products; and pKa PRO to measure acid dissociation constants of water-soluble and insoluble compounds. The company also provides installation, training, warranty, and technical support services. It offers its products through a network of distributors and support centers. Advanced Analytical Technologies, Inc. was incorporated in 1997 and is based in Ames, Iowa. It has a laboratory and a sales office in Heidelberg, Germany. As of May 31, 2018, Advanced Analytical Technologies, Inc. operates as a subsidiary of Agilent Technologies, Inc.

Luxcel Biosciensces Ltd.

Acquisition in 2018
Luxcel Biosciences was founded in 2002 in Co. Cork, Ireland, to commercialise cutting-edge, porphyrin-based, phosphorescent, oxygen-sensing probes and oxygen sensors, with initial applications targeted at the pharmaceutical, food safety and packaging industries. Our aim at Luxcel Biosciences is to produce fluorescence and phosphorescence-based tools that will provide direct benefits for our customers. These benefits include increased speed and accuracy, reduced research and development (R&D) costs for manufacturers, and safer products for consumers.

NanoCellect Biomedical

Series B in 2017
NanoCellect Biomedical develops and delivers microfluidic-based solutions that are affordable, compact, and easy to use. Its expanding portfolio of instruments and consumables enables biomedical scientists to analyze and sort cells required for drug discovery, single cell-omics, cloning, antibody discovery, and basic research.

Agilent Raman Spectroscopy

Acquisition in 2017
Agilent Raman Spectroscopy’s proprietary technologies use novel variants of Raman spectroscopy. Their instruments can rapidly and accurately identify materials hidden inside objects or through opaque barriers such as plastic, coloured glass, paper and skin, or can measure the concentrations of materials in mixtures, with a high degree of accuracy. Agilent Raman Spectroscopy is formerly known as Cobalt Light Systems and is part of Agilent.

Multiplicom

Acquisition in 2016
Multiplicom develops molecular diagnostics products for medical genetics, and clinical laboratory-based tests.

Molecular Assemblies

Seed Round in 2016
Molecular Assemblies is a San Diego-based company developing a revolutionary, enzymatic DNA synthesis technology capable of powering new products in industrial synthetic biology, personalized therapeutics, precision diagnostics, and eventually information storage, nanotechnology and more. Inspired by nature, the company’s proprietary DNA synthesis method is designed to produce long, high quality, sequence-specific DNA reliably, affordably and sustainably. With a highly experienced executive and scientific team and an expansive intellectual property portfolio, Molecular Assemblies has attracted investments from Agilent Technologies, Cavendish Impact Capital Fund, Data Collective Venture Capital, Eleven Two Capital, Genomics Investment Syndicate, Keshif Ventures, Newport Holdings, LP, and Alexandria Venture Investments.

iLab Solutions

Acquisition in 2016
iLab Solutions is a leader in providing web-based management services to academic research institutions, with customers that include leading NIH-funded universities, research hospitals, and independent institutes. iLab leverages a scientific advisory team comprised of active PIs with research backgrounds from Brigham & Women’s Hospital, Dana-Farber Cancer Institute, EMBL, Harvard, Huntsman Cancer Institute, Mt. Sinai School of Medicine, Stanford University, University of Melbourne, , and Yale University. The iLab leadership team includes executives with experience from Dana-Farber Cancer Institute, Deloitte, Facebook, Genentech, Intel, McKinsey, Microsoft, and SAIC. With vast experience and a broad customer base, iLab is a stable partner for research institutions. iLab enjoys a rapidly-growing customer base with greater than 100% year-on-year growth. iLab has extensive experience providing enterprise-level solutions at major research institutions. These solutions include integrations with institutional financial systems (e.g., SAP, Oracle, PeopleSoft, Lawson, Banner, IFAS, etc.) and identity management systems (e.g., Active Directory, Shibboleth, etc.). iLab’s dedicated implementation team and established implementation processes result in high adoption and fully trained personnel for effective use of the system. In order to ensure stability, security, scalability, and responsiveness, iLab conducts all software development, application maintenance, deployment, and user support internally. This internally-resourced approach results in a close relationship between iLab and our customers and ensures iLab can rapidly address customer needs. iLab offers a suite of web-based tools for academic research management. The functionality includes core facility service request management, enhanced sample management functionality, equipment reservation and usage tracking, billing and invoicing, reporting, and lab requisitioning and spend tracking tools. The system also allows each user a consolidated view of their recent activity in the system as well as the ability to search across all equipment, services and cores in the system.

Lasergen

Series B in 2016
LaserGen, Inc., a biotechnology company, engages in the development and commercialization of technologies for genomics application. It develops various technologies for sequencing applications. The company's products detect heritable and somatic sequence variations in the human genome for use as diagnostics tools for the management of diseases. LaserGen, Inc. was incorporated in 2002 and is based in Houston, Texas.

Seahorse Bioscience

Acquisition in 2015
Seahorse Bioscience provides analytical instruments, biomanufacturing systems and consumable labware products for biological research and drug discovery. The company's customers include scientists at academic institutions, pharmaceutical and biotech organizations, as well as OEM manufacturers of assay kits and lab instruments suppliers.

Cartagenia

Acquisition in 2015
Cartagenia delivers expert systems and services to enable genetic labs and clinicians to perform clinically relevant genetic analyses quickly and efficiently, and offer patients and carers high quality genetic interpretation and counseling.

Gradient Design Automation

Acquisition in 2014
Gradient Design Automation, Inc. offers electro-thermal analysis software that produces a 3-dimensional temperature map of a chip or SiP.

Gen9

Private Equity Round in 2013
Gen9 is building on advances in synthetic biology to power a scalable fabrication capability that will significantly increase the world’s capacity to produce DNA content. The privately held company’s next-generation gene synthesis technology allows for the high-throughput, automated production of DNA constructs at lower cost and higher accuracy than previous methods on the market. Founded by world leaders in synthetic biology, Gen9 aims to ensure the constructive application of synthetic biology in industries ranging from enzyme and chemical production to pharmaceuticals and biofuels. Gen9 was established in 2009 and is based in Cambridge, Massachusetts, United States.

Aurora SFC Systems

Acquisition in 2012
Aurora SFC Systems, Inc. develops and manufactures supercritical fluid chromatography (SFC) products for normal phase separation in laboratory environments in the United States and internationally. The company offers Agilent 1260 Infinity Analytical SFC system, a modular system that consists of the Agilent 1260 Analytical SFC LC and the Aurora SFC Fusion A5 Evolution for pre- and post- conditioning of carbon dioxide.

Dako Denmark

Acquisition in 2012
Dako Denmark A/S provides reagents, instruments, and software for cancer diagnostics to hospital and research laboratories worldwide. It offers pathology products, including reagents and antibodies; pharmacodiagnostic kits and pharmDx; staining instruments and instruments for image analysis; and systems where instruments, reagents, training, and service are integrated, which are used by pathologists for in vitro diagnostics to diagnose cancer and other chronic diseases on the basis of tissue samples. The company also provides flow cytometry products comprising reagents and accessories; instruments for flow cytometry; and systems that are used to analyze cells in blood and other fluids, and are employed in the diagnosis of leukemia, lymphoma, and other diseases. In addition, Dako Denmark A/S offers antibodies, which are used to measure the concentration of protein in blood, urine, and cerebrospinal fluid. It has collaboration with Genentech, OSI Pharmaceuticals, and Roche for the clinical development and application for a Premarket Approval Supplement and CE marking of EGFR pharmDx for use of the EGFR pharmDx test as a potential aid in the assessment of non-small cell lung cancer patients considered for treatment with Tarceva. The company was founded in 1966 and is headquartered in Glostrup, Denmark. Dako was acquired by Agilent Technologies in 2012.

Accelicon Technologies

Acquisition in 2011
Accelicon Technologies, a privately held company that provides device-level modeling and validation software for the electronics industry. Accelicon sells the SPICE model analysis solution for model quality assurance. Accelicon s MQA solution provides a model verification platform and a link between fab and design, comparing, documenting and validating foundry-supplied models. Accelicon also offers a modeling platform, MBP, that allows modeling engineers to optimize the SPICE model library in order to best reflect silicon data and meet the requirements for a specific type of design.

Halo Genomics

Acquisition in 2011
A description for Halo Genomics is coming soon.

Biosystem Development

Acquisition in 2011
BioSystem Development creates, manufactures, and markets system products for unmet needs in the fields of biotechnology and life science research.

Lab901

Acquisition in 2011
Lab901 Limited engages in the development and production of automated gel electrophories in the United Kingdom. It offers ScreenTape P200 variant, which allows scientists in expressing and purifying recombinant proteins and monoclonal antibodies to carry out SDS-PAGE and analysis; ScreenTape R6K that is developed for reproducible RNA characterisation and quality control; and ScreenTape D800, which separates DNA fragments.

BIOCIUS Life Sciences

Acquisition in 2011
BIOCIUS Life Sciences, Inc. engages in the drug discovery research. The company was incorporated in 2009 and is based in Woburn, Massachusetts. BIOCIUS Life Sciences, Inc. operates as a subsidiary of BioTrove, Inc.

Novelx

Acquisition in 2010
Novelx, which was incorporated in 2002 to make low-cost, high-resolution electron beam columns for inspection, analysis and lithography applications.

Varian

Acquisition in 2009
Varian, Inc. is a leading worldwide supplier of scientific instruments and vacuum technologies for life science and industrial applications. The company provides complete solutions, including instruments, vacuum products, laboratory consumable supplies, software, training and support through its global distribution and support systems. Varian, Inc. employs approximately 3,900 people worldwide and operates manufacturing facilities in North America, Europe and Asia Pacific. Varian, Inc. had fiscal year 2008 sales of $1.0 billion.

MTS Nano Instruments

Acquisition in 2008
MTS Nano Instruments, Inc. develops and supplies equipment and software to determine the mechanical behavior of nano-scale materials and structures. Its products include nano-indentation systems, nanomechanical testing systems, and quantitative imaging systems. The company's products also include TestWorks Professional, a nanomechanical testing software; TestWorks Explorer, which enables users to define control channels, as well as design test methods; TestWorks 3D that automates scanning processes; Virtual Indenter, an analysis tool, which enables users to setup, execute, and analyze finite-element simulations of the indentation experiments; and Analyst, a data analysis assistant. In addition, it offers contract and educational services. The company's products are used for verifying the structural integrity of semiconductor devices, coatings, and thin films. It serves academic and industrial researchers involved in the areas of materials sciences, semiconductor, and life sciences. MTS Nano Instruments, Inc. was formerly known as Nano Instruments, Inc. The company was incorporated in 1983 and is based in Oak Ridge, Tennessee. As of June 27, 2008, MTS Nano Instruments, Inc. operates as a subsidiary of Agilent Technologies, Inc.

RVM Scientific

Acquisition in 2008
RVM Scientific, Inc. manufactures direct heating/cooling systems for gas chromatography capillary columns. The company’s products include low thermal mass retrofits and thermal desorber tubes. It also offers custom gas chromatography modules, which are used for low power consumption applications for portable instruments; high speed separations that use short narrow-bore columns; and column modules with metal columns that are used for high temperature applications.

Escort Instruments

Acquisition in 2008
Escort Instruments Corporation manufactures test and measurement instruments. The company focuses on offering general purpose test instruments, process test tools, and automotive diagnosis tools. Escort Instruments provides its products through a network of distributors worldwide.

TILL Photonics

Acquisition in 2008
TILL provides extremely flexible, modular systems for all current and future microscopy standards – and complete turnkey solutions for imaging and photometry systems. The majority of TILL’s customers are found in the fields of neurobiology, cell biology, biomedicine and pharmacology. The company’s headquarters are located in the Munich BioRegio (Germany), TILL Photonics’ US operation is based in Rochester, NY

Velocity11

Acquisition in 2007
Velocity11 is a life sciences technology company that designs and manufactures automation solutions for life science researchers. The company provides instruments which includes liquid handling microplate management products; and BioCel, a sample processing powerhouse for assembling genomics reactions, dispensing samples for compound preparation, or processing biological samples in screening applications. Velocity11 is headquartered in the United States. The company was founded in 1999 by Travis Chow.

Kalabie

Acquisition in 2007
Kalabie is an Electronic Lab Notebook (ELN) software vendor. Born in 2000, Kalabie was one of the few companies that position itself in the Pharma/Medicinal Chemistry market that later became the beach-head market for growth of the ELN category. Kalabie was funded by the Klee Group, an IT-services and software company based in France and with operations in Europe. Kalabie won a number of clients in Europe and particularly built a strong presence in Sanofi-Aventis. From 2004, the company experienced a steady growth and increased its worldwide presence and reinforced its status as one of the leading solution in this market. The ELN opportunity was rapidly seen by larger Software Vendors and Lab Equipment Manufacturer as a strategic offering in their portfolio and Kalabie was acquired by Agilent Technologies Inc. in 2007.

Stratagene

Acquisition in 2007
Stratagene Corporation develops, manufactures, and markets life science research products in the United States and internationally. The company supports advances in science by inventing, manufacturing, and distributing products that simplify, accelerate, and improve research. Its products are used in the academic, industrial, and government research sectors in fields spanning molecular biology, genomics, proteomics, drug discovery, and toxicology.

PXIT

Acquisition in 2006
PXIT, Inc. develops and manufactures test and measurement systems, primarily for use in high-speed data communications. It also offers signal integrity testing solutions for broadband electro-optical signals. The company’s products include digital communications analyser, bit error rate tester, pattern generator, and synthesizer. It offers its products to telecommunications, data communications, and lighting markets.

Acqiris

Acquisition in 2006
Acqiris SA, a privately held company that provides high-speed digitizers and analyzers used in commercial, industrial and government electronics markets.

Xpedion Design Systems

Acquisition in 2006
Xpedion Design Systems, Inc. provides transistor-level simulation, analysis, and behavioral modeling solutions to radio frequency integrated circuit or wireless and system-on-chip designers.

SynPro

Acquisition in 2006
SynPro Corp. manufactures short synthetic DNA and RNA molecules for the pharmaceutical and biotech industries. Its products are used as components of drugs in clinical trials. It makes synthetic nucleic acids used in biotech research.

Molecular Imaging Corp.

Acquisition in 2005
Molecular Imaging Corp. is a developer and manufacturer of nanotechnology measurement tools.

Computational Biology

Acquisition in 2005
Computational Biology Corp. develops microarray-based techniques for understanding gene regulation in disease. The company utilizes ChIP-on-chip technology, which uses chromatin immuno-precipitation (ChIP) to discover how regulatory proteins interact with the genome of living cells.

Silicon Genetics

Acquisition in 2004
Silicon Genetics provides data analysis and management solutions focusing on molecular biology, statistics, and IT. The company’s products include GeneSpring, a visualization and analysis solution for genomic expression data on the desktop; Varia, which is genetic analysis software for life science researchers; and GeNet, provides scalable repository for expression data.

Sirific Wireless

Series B in 2004
Sirific Wireless is a semiconductor company, designs and develops CMOS RF HEDGE transceivers for wireless communications market. The company offers monolithic multi-mode wireless design and digital direct conversion products; Harmony-direct upconversion transmitters; and NEXUS products, NexusRD. Its NEXUS platform combines HSDPA, WCDMA, EDGE, GPRS, and GSM with available on-chip receive diversity to deliver transceivers for multi-mode and multi-band wireless applications. The company has locations in Waterloo, Canada; Richardson, Texas; and Seoul, Korea. Sirific Wireless Limited was founded in 2000 and is headquartered in Richardson, Texas with additional offices in the United States, Canada, and Korea.

TelASIC Communications

Series C in 2003
TelASIC Communications, Inc. develops remote radio head products for WCDMA/HSDPA and WiMAX/LTE infrastructure applications. The company's products enable the transmission of high output power to deliver high data rates and coverage for mobile TV/video/audio/data-centric 3G data services. TelASIC Communications, Inc. was founded in 2001 and is based in El Segundo, California.

RedSwitch

Acquisition in 2002
RedSwitch is a supplier of high performance switch fabric silicon solutions for the storage, server, networking, and telecom markets. Incorporated in June 2000 with headquarters in Milpitas, Calif., the company was formed by senior executives and design professionals from HAL Computer Systems Inc. RedSwitch products support leading interconnect standards including InfiniBand(TM), RapidIO (TM), and PCI-Express(TM).

SAN Valley Systems

Series C in 2002
SAN Valley is a privately held Silicon Valley company whose mission is to deliver high reliability, cost effective, next generation storage infrastructure solutions to enterprise and service providers worldwide. SAN Valley is developing high performance end-to-end optical edge access products to address the multi-billion dollar market opportunity for delivering value-added storage connectivity into enterprise, service provider and carrier networks.

Big Bear Networks

Series B in 2002
Big Bear Networks develops optical transponders and subassemblies for network operators.

Qosnetics

Acquisition in 2002
Qosnetics develops IP-based conformance verification and performance-stressing tools.

Tropian

Series D in 2001
Tropian, Inc. develops and provides multimode radio frequency integrated circuits and solutions for wireless devices. The company offers Timestar radio frequency integrated circuit solutions for quad-band cellular handsets; Codestar radio transceivers; and Multistar transceivers. It serves wireless device manufacturers. Tropian, Inc. was formerly known as Premier R.F., Inc.

Wavefront Research

Acquisition in 2001
Wavefront Research, Inc. develops optical systems and technologies that solve problems evading conventional solutions. Its technologies include low-loss 1xN and MxN optical switches, compact optical time delay systems, dense alignment-tolerant intra-board VCSEL-based optical interconnects, dense alignment-tolerant board-to-board VCSEL-based optical interconnects, and ultra-lightweight and compact hyperspectral imagers.

Novera Optics

Venture Round in 2001
Novera Optics develops optical access solutions. Its PON optical solutions enable equipment vendors and service providers to address fiber-to-the-building, fiber-to-the-curb extensions, multi-dwelling and multi-tenant units, remote terminals, and the central office markets. The company offers Wavelength Division Multiplexed-Passive Optical Networks (WDM-PON), an access and transport platform, which provides an architecture for access networks that enables service providers to deliver voice, data, video, and wireless services.
Agilent's Interoperability Certification Labs, Inc. provides third party product testing services. It specializes in test and analysis services, such as performance; benchmarking; interoperability; and functional, certification, and conformance testing. The company offers its services to original equipment manufacturers, systems integrators, and industry groups.

MV Technology

Acquisition in 2001
MV Technology Ltd. provides automated optical-inspection systems and solutions for the electronics-manufacturing market.

ATN Microwave

Acquisition in 2000
ATN Microwave specializes in microwave measurement solutions for wireless and high-speed data communication applications.

Objective Systems Integrators

Acquisition in 2000
OSI is a global provider of Operations Support Systems (OSS) solutions for communications service providers. OSI’s flagship NetExpert® platform provides visibility and service assurance for the largest service providers in the world, as well as innovative providers of next-generation services such as LTE. With worldwide presence through sales offices and local partners, OSI has established its leadership in product and service innovations since its founding in 1989. The NetExpert® platform is used by leading Communications Service Providers (fixed, broadband, and wireless companies) to manage their networks, services, products, and customers. NetExpert® provides service, performance and fault management for large-scale complex networks, and provides both aggregate-up and drill-down visibility into the quality of the service down to a customer-level.

Entridia

Series C in 2000
Entridia Corporation is an Internet infrastructure company that builds revolutionary silicon and system solutions for next generation converged data and voice internets. Our products and services will empower leading edge Router System OEMs to build the Internet gateways of tomorrow.

SAN Valley Systems

Series B in 2000
SAN Valley is a privately held Silicon Valley company whose mission is to deliver high reliability, cost effective, next generation storage infrastructure solutions to enterprise and service providers worldwide. SAN Valley is developing high performance end-to-end optical edge access products to address the multi-billion dollar market opportunity for delivering value-added storage connectivity into enterprise, service provider and carrier networks.

Zymed

Acquisition in 2000
Zymed, Inc. develops and markets inpatient telemetry systems, cardiac analysis software algorithms, and outpatient holter and cardiac event monitoring systems. It serves diagnostic monitoring markets, which include holter, telemetry, event recorder, home cardiac monitoring, intensive/coronary care units, prevention analysis, interventional cardiology, and arrhythmia and ischemia disease management.

American Holographic

Acquisition in 2000
American Holographic Inc designs and manufactures holographic diffraction gratings and spectral sensor modules that are used in fiber optic communications, optical test equipment, color measurement, pulse compression, spectrographs and industrial research and scientific applications.

J&W Scientific

Acquisition in 2000
J&W Scientific, Inc. manufactures scientific instruments such as high resolution gas chromatography columns, flowmeters, syringes, and gas flow and control instruments. The company produces Unimetrics Syringes, Humonics Flowmeters and R&D Separations Gas Filters.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.